Mechanisms driving local breast cancer recurrence in a model of breast-conserving surgery.
AuthorsSmith, Myles J
Culhane, Aedin C
Kelly, Maura A
Wang, Jiang H
Cotter, Thomas G
Redmond, Henry P
AffiliationDepartment of Academic Surgery, Cork University Hospital, Cork, Ireland., firstname.lastname@example.org
Cancer Vaccines/therapeutic use
*Disease Models, Animal
Gene Expression Profiling
Heat-Shock Proteins/therapeutic use
Mice, Inbred BALB C
Neoplasm Recurrence, Local/*diagnosis/metabolism
Oligonucleotide Array Sequence Analysis
Proto-Oncogene Proteins c-akt/metabolism
Reverse Transcriptase Polymerase Chain Reaction
Tumor Cells, Cultured
Tumor Markers, Biological/genetics/metabolism
MetadataShow full item record
CitationAnn Surg Oncol. 2008 Oct;15(10):2954-64. Epub 2008 Jul 12.
JournalAnnals of surgical oncology
AbstractOBJECTIVE: We aimed to identify mechanisms driving local recurrence in a model of breast-conserving surgery (BCS) for breast cancer. BACKGROUND: Breast cancer recurrence after BCS remains a clinically significant, but poorly understood problem. We have previously reported that recurrent colorectal tumours demonstrate altered growth dynamics, increased metastatic burden and resistance to apoptosis, mediated by upregulation of phosphoinositide-3-kinase/Akt (PI3K/Akt). We investigated whether similar characteristics were evident in a model of locally recurrent breast cancer. METHODS: Tumours were generated by orthotopic inoculation of 4T1 cells in two groups of female Balb/c mice and cytoreductive surgery performed when mean tumour size was above 150 mm(3). Local recurrence was observed and gene expression was examined using Affymetrix GeneChips in primary and recurrent tumours. Differential expression was confirmed with quantitative real-time polymerase chain reaction (qRT-PCR). Phosphorylation of Akt was assessed using Western immunoblotting. An ex vivo heat shock protein (HSP)-loaded dendritic cell vaccine was administered in the perioperative period. RESULTS: We observed a significant difference in the recurrent 4T1 tumour volume and growth rate (p < 0.05). Gene expression studies suggested roles for the PI3K/Akt system and local immunosuppression driving the altered growth kinetics. We demonstrated that perioperative vaccination with an ex vivo HSP-loaded dendritic cell vaccine abrogated recurrent tumour growth in vivo (p = 0.003 at day 15). CONCLUSION: Investigating therapies which target tumour survival pathways such as PI3K/Akt and boost immune surveillance in the perioperative period may be useful adjuncts to contemporary breast cancer treatment.
- Targeting fibroblast growth factor receptors blocks PI3K/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis.
- Authors: Dey JH, Bianchi F, Voshol J, Bonenfant D, Oakeley EJ, Hynes NE
- Issue date: 2010 May 15
- Phosphoinositide 3-kinase targeting by the beta galactoside binding protein cytokine negates akt gene expression and leads aggressive breast cancer cells to apoptotic death.
- Authors: Wells V, Mallucci L
- Issue date: 2009
- Identification of survival-related genes of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma multiforme.
- Authors: Ruano Y, Mollejo M, Camacho FI, Rodríguez de Lope A, Fiaño C, Ribalta T, Martínez P, Hernández-Moneo JL, Meléndez B
- Issue date: 2008 Apr 1
- Loss of beta4 integrin subunit reduces the tumorigenicity of MCF7 mammary cells and causes apoptosis upon hormone deprivation.
- Authors: Bon G, Folgiero V, Bossi G, Felicioni L, Marchetti A, Sacchi A, Falcioni R
- Issue date: 2006 Jun 1
- Gene expression profile by inhibiting Raf-1 protein kinase in breast cancer cells.
- Authors: Mewani RR, Tian S, Li B, Danner MT, Carr TD, Lee S, Rahman A, Kasid UN, Jung M, Dritschilo A, Gokhale PC
- Issue date: 2006 Mar